Report of the 2023-2024 Strategic Engagement Standing Committee

被引：0
|
作者：
Palombi, Laura C. [1 ]
Silvia, Richard [2 ]
Dugan, Sara [3 ]
Khan, Md Omar Faruk [4 ]
Kawahara, Brian I. [5 ]
O'Neal, Katherine S. [6 ]
Robinson, Evan [7 ]
Tyler, Linda [8 ]
Unni, Elizabeth [9 ]
Shrader, Sarah [10 ]
Moore, Terri [10 ]
机构：
[1] Univ Minnesota, Coll Pharm, Duluth, MN 55812 USA
[2] Massachusetts Coll Pharm & Hlth Sci, Boston, MA USA
[3] Northeast Ohio Med Univ, Rootstown, OH USA
[4] Univ Charleston, Sch Pharm, Charleston, WV USA
[5] Chapman Univ, Sch Pharm, Irvine, CA USA
[6] Univ Oklahoma, Hlth Sci Ctr, Coll Pharm, Oklahoma City, OK USA
[7] Creighton Univ, Sch Pharm & Hlth Profess, Omaha, NE USA
[8] Univ Utah, Coll Pharm, Salt Lake City, UT USA
[9] Touro Coll Pharm, New York, NY USA
[10] Amer Assoc Coll Pharm, Arlington, VA USA
来源：
AMERICAN JOURNAL OF PHARMACEUTICAL EDUCATION | 2024年 / 88卷 / 08期
关键词：
AACP; Advocacy; Champions; Partnerships; Stakeholders;
D O I：
10.1016/j.ajpe.2024.100752
中图分类号：
G40 [教育学];
学科分类号：
040101 ; 120403 ;
摘要：
The American Association of Colleges of Pharmacy has long emphasized the value of strategic engagement, recognizing that it is critical to the success of pharmacy education, contributing to the expansion of pharmacy and public health practice, the fulfillment of institutional missions, and the meeting of programmatic needs. The 2023-2024 Strategic Engagement Committee was charged with operationalizing advocacy champions, creating an advocacy resource guide to support advocacy champions in their engagement with diverse public and private stakeholders, offering formal training to advocacy champions in the form of a new connect community and webinar series, and conducting focus groups at the 2024 Annual Meeting to determine strengths of the advocacy guide and opportunities to support advocacy champions further.
引用
收藏
页数：4
相关论文
共 50 条
  • [31] Historical Pedagogical Educational Reports 2023-2024
    Chiosso, Giorgio
    HISTORY OF EDUCATION & CHILDRENS LITERATURE, 2024, 19 (02):
  • [32] New Novavax Vaccine Formulation for 2023-2024
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2023, 65 (1689): : 182 - 183
  • [33] "CHINESE COASTER" - 2: AT THE TURN OF 2023-2024
    Mikheev, Vasily V.
    Lukonin, Sergei A.
    MIROVAYA EKONOMIKA I MEZHDUNARODNYE OTNOSHENIYA, 2024, 68 (07):
  • [34] Equine Encephalomyelitis Outbreak, Uruguay, 2023-2024
    Frabasile, Sandra
    Morel, Noelia
    Perez, Ramiro
    Marrero, Lucia Moreira
    Burgueno, Analia
    Cortinas, Maria Noel
    Bassetti, Lucia
    Negro, Raul
    Rodriguez, Sirley
    Bormida, Victoria
    Gayo, Valeria
    de Souza, Victor Costa
    Naveca, Felipe Gomes
    Gomez, Mariela Martinez
    Gresh, Lionel
    Mendez-Rico, Jairo
    Chiparelli, Hector
    Delfraro, Adriana
    EMERGING INFECTIOUS DISEASES, 2025, 31 (01) : 180 - 183
  • [35] Influenza vaccine for 2023-2024 (vol 65, pg 161, 2023)
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2023, 65 (1689): : 184 - 184
  • [36] The Year in Review: Economics at the Antitrust Division 2023-2024
    Athey, Susan
    Gross, Alex
    Marinescu, Ioana
    Shanefelter, Jennifer
    REVIEW OF INDUSTRIAL ORGANIZATION, 2024, : 809 - 829
  • [37] American Board of Emergency Medicine Report on Residency and Fellowship Training Information (2023-2024)
    Gaeta, Theodore J.
    Ankel, Felix K.
    Calderon, Yvette
    Holden, Lynne
    Knapp, Barry J.
    Marshall, John P.
    Purosky, Robert G.
    Johnston, Mary M.
    ANNALS OF EMERGENCY MEDICINE, 2024, 84 (01) : 65 - 81
  • [38] Analysis and Prospects of the World Economic Situation 2023-2024
    Zhang Yuyan
    Xu Xiujun
    ContemporaryWorld, 2024, (01) : 27 - 31
  • [39] Note from the Editor and Acknowledgment of Reviewers 2023-2024
    Norman, Emma R.
    POLITICS & POLICY, 2024, 52 (06) : 1198 - 1209
  • [40] Current topic of vascular function in hypertension in 2023-2024
    Maruhashi, Tatsuya
    Higashi, Yukihito
    HYPERTENSION RESEARCH, 2024, 47 (12) : 3310 - 3317
12345